Publications
Publications
- Author Correction: Apolipoprotein E controls cerebrovascular integrity via cyclophilin A.; Nature. 2023 May 05.
- Uptake of severe acute respiratory syndrome coronavirus 2 spike protein mediated by angiotensin converting enzyme 2 and ganglioside in human cerebrovascular cells.; Frontiers in neuroscience; Vol 17, pp. 1117845. 2023 Feb 16.
- Spike protein multiorgan tropism suppressed by antibodies targeting SARS-CoV-2.; Communications biology; Vol 4(1). 2021 Nov 22.
- Response to the letter, entitled "Role of hemagglutinin esterase protein in neurological manifestation of COVID-19".; Fluids and barriers of the CNS; Vol 18(1). 2021 Sep 03.
- SARS-CoV-2: is there neuroinvasion?; Fluids and barriers of the CNS; Vol 18(1). 2021 Jul 14.
- Cerebrospinal fluid drainage kinetics across the cribriform plate are reduced with aging.; Fluids and barriers of the CNS; Vol 17(1). 2020 Nov 30.
- Erratum to: Glymphatic distribution of CSF-derived apoE into brain is isoform specific and suppressed during sleep deprivation.; Molecular neurodegeneration; Vol 12(1). 2017 Jan 12.
- Glymphatic distribution of CSF-derived apoE into brain is isoform specific and suppressed during sleep deprivation.; Molecular neurodegeneration; Vol 11(1). 2016 Dec 08.
- Glymphatic clearance controls state-dependent changes in brain lactate concentration.; Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 2016 Aug 1.
- Suppression of glymphatic fluid transport in a mouse model of Alzheimer's disease.; Neurobiology of disease. 2016 May 24.
- The Effect of Body Posture on Brain Glymphatic Transport.; The Journal of neuroscience : the official journal of the Society for Neuroscience; Vol 35(31). 2015 Aug 5.
- Biomarkers of Traumatic Injury Are Transported from Brain to Blood via the Glymphatic System.; The Journal of neuroscience : the official journal of the Society for Neuroscience; Vol 35(2). 2015 Jan 14.
- Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury.; The Journal of neuroscience : the official journal of the Society for Neuroscience; Vol 34(49). 2014 Dec 03.
- Impairment of paravascular clearance pathways in the aging brain.; Annals of neurology; Vol 76(6). 2014 Dec.
- The spectrum of neurobehavioral sequelae after repetitive mild traumatic brain injury: a novel mouse model of chronic traumatic encephalopathy.; Journal of neurotrauma; Vol 31(13). 2014 Jul 01.
- Direct neuronal glucose uptake heralds activity-dependent increases in cerebral metabolism.; Nature communications; Vol 6. 2015.
- The pathophysiology underlying repetitive mild traumatic brain injury in a novel mouse model of chronic traumatic encephalopathy.; Surgical neurology international; Vol 5. 2014.
- Cerebral arterial pulsation drives paravascular CSF-interstitial fluid exchange in the murine brain.; The Journal of neuroscience : the official journal of the Society for Neuroscience; Vol 33(46). 2013 Nov 13.
- Sleep drives metabolite clearance from the adult brain.; Science (New York, N.Y.); Vol 342(6156). 2013 Oct 18.
- Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance.; Proceedings of the National Academy of Sciences of the United States of America; Vol 110(36). 2013 Sep 03.
- Paravascular microcirculation facilitates rapid lipid transport and astrocyte signaling in the brain.; Scientific reports; Vol 3. 2013.
- A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β.; Science translational medicine; Vol 4(147). 2012 Aug 15.
- Apolipoprotein E controls cerebrovascular integrity via cyclophilin A.; Nature; Vol 485(7399). 2012 May 16.
- A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease.; The Journal of clinical investigation; Vol 122(4). 2012 Apr.
- Methamphetamine causes sustained depression in cerebral blood flow.; Brain research; Vol 1373. 2011 Feb 10.
- Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-β is an early biomarker for mild cognitive impairment preceding Alzheimer's disease.; Journal of Alzheimer's disease : JAD; Vol 24(1). 2011.
- Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid β-peptide elimination from the brain.; Journal of neurochemistry; Vol 115(5). 2010 Dec.
- Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging.; Neuron; Vol 68(3). 2010 Nov 04.
- Protein S controls hypoxic/ischemic blood-brain barrier disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor.; Blood; Vol 115(23). 2010 Jun 10.
- Impaired spine formation and learning in GPCR kinase 2 interacting protein-1 (GIT1) knockout mice.; Brain research; Vol 1317. 2010 Mar 4.
- Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells.; The Journal of clinical investigation; Vol 119(11). 2009 Nov.
- Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.; CNS & neurological disorders drug targets; Vol 8(1). 2009 Mar.
- Neuroprotective activities of activated protein C mutant with reduced anticoagulant activity.; The European journal of neuroscience; Vol 29(6). 2009 Mar.
- SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells.; Nature cell biology; Vol 11(2). 2009 Feb.
- Endothelial protein C receptor-assisted transport of activated protein C across the mouse blood-brain barrier.; Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism; Vol 29(1). 2009 Jan.
- apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain.; The Journal of clinical investigation; Vol 118(12). 2008 Dec.
- ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration.; Nature neuroscience; Vol 11(4). 2008 Apr.
- The role of the cell surface LRP and soluble LRP in blood-brain barrier Abeta clearance in Alzheimer's disease.; Current pharmaceutical design; Vol 14(16). 2008.
- Clearance of amyloid-beta by circulating lipoprotein receptors.; Nature medicine; Vol 13(9). 2007 Sep.
- Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system.; Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism; Vol 27(5). 2007 May.
- Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.; Current Alzheimer research; Vol 4(2). 2007 Apr.
- Two-photon imaging of astrocytic Ca2+ signaling and the microvasculature in experimental mice models of Alzheimer's disease.; Annals of the New York Academy of Sciences; Vol 1097. 2007 Feb.
- Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype.; Proceedings of the National Academy of Sciences of the United States of America; Vol 104(3). 2007 Jan 16.
- Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease; Current Alzheimer's Research; Vol 4, pp. 191-197. 2007 Jan 01.
- Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J.; J Cerebral Blood flow and Metabolism; Vol 27, pp. 909-918. 2007 Jan 01.
- Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease; Current Alzheimer's Research; Vol 4, pp. 191-197. 2007 Jan 01.
- Role of transthyretin in thyroxine transfer from cerebrospinal fluid to brain and choroid plexus; American Journal of Physiology - Regulatory Integrative & Comparative Physiology; Vol 291(5), pp. 1310-1315. 2006 Jan 01.
- Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage.; Nature medicine; Vol 12(11). 2006 Nov.
- IgG-assisted age-dependent clearance of Alzheimer's amyloid beta peptide by the blood-brain barrier neonatal Fc receptor.; The Journal of neuroscience : the official journal of the Society for Neuroscience; Vol 25(50). 2005 Dec 14.
- P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model.; The Journal of clinical investigation; Vol 115(11). 2005 Nov.